Drug Approval | October 06, 2025
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Ultra-high purity surfactant for biologics and parenteral drug formulations
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Merck opens first climate-neutral manufacturing facility in Ireland
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Subscribe To Our Newsletter & Stay Updated
